Effect of losartan on lung fibrosis in neonatal rats with hyperoxia-induced chronic lung disease

Chinese Journal of Contemporary Pediatrics

Volumn 9, Issue 6, 2007, Pages

  Chen, Ning ^a   Li, Jie Jun ^a   Xue, Xin Dong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chronic lung disease; Hyperoxia; Losartan; Lung fibrosis; Neonatal rats; Oxidative stress

Indexed keywords

HYDROXYPROLINE; LOSARTAN; MALONALDEHYDE; PLACEBO; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENUATION; BLOOD GAS ANALYSIS; CHRONIC LUNG DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; DRUG MECHANISM; HISTOPATHOLOGY; HYPEROXIA; LIPID PEROXIDATION; LUNG ALVEOLUS; LUNG FIBROSIS; LUNG HEMORRHAGE; LUNG PARENCHYMA; NEWBORN; NONHUMAN; RAT; SPECTROSCOPY; STAINING; WISTAR RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; HUMANS; HYDROXYPROLINE; HYPEROXIA; INFANT, NEWBORN; LOSARTAN; LUNG; MALONDIALDEHYDE; PULMONARY FIBROSIS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 38049007343     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease: broncho pulmonary dysplasia[J]. N Engl J Med, 1967, 276(7):357-368.
2. Marshall RP, McAnulty RJ, Laurent GJ. Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor[J]. Am J Respir Crit Care Med, 2000, 161(6): 1999-2004.
3. Wang R, Zagariya A, Ibarra-Sunga O, Gidea C, Ang E, Deshmukh S, et al. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells[J]. Am J Physiol, 1999, 276(5 Pt 1): L885-L889.
4. Chinese source.
5. Cherukupalli K, Larson JE, Rotschild A, Thurlbeck WM. Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia [J]. Pediatr Pulmonol, 1996, 22(4):215-29.
6. Otsuka M, Takahashi H, Shiratori M, Chiba H, Abe S. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist [J]. Thorax, 2004, 59 (1):31-38.
7. Mancini GB, Khalil N. Angiotensin II type 1 receptor blocker inhibits pulmonary injury[J]. Clin Invest Med, 2005, 28(3):118-126.
8. Yao HW, Zhu JP, Zhao MH, Lu Y. Losartan attenuates bleomycin-induced pulmonary fibrosis in rats[J]. Respiration, 2006, 73 (2):236-242.
9. Inder TE, Graham P, Sanderson K, Taylor BJ. Lipid peroxidation as a measure of oxygen free radical damage in the very low birth-weight infant [J]. Arch Dis Child Fetal Neonatal Ed, 1994, 70 (2):F107-111.
10. Varsila E, Pesonen E, Andersson S. Early protein oxidation in the neonatal lung is related to development of chronic lung disease [J]. Acta Paediatr, 1995, 84(11):1296-1299.
11. Chinese source.
12. Bowler RP, Crapo JD. Oxidative stress in airways: Is there a role for extracellular superoxide dismutase [J]. Am J Respir Crit Care Med, 2002, 166 (12 Pt 2):S38-43.
13. Davis J, Rosenfeld W, Parad R, Richter S, Gewolb L, Couser R, et al. Improved pulmonary outcome at one year corrected age in premature neonates treated with recombinant human superoxide dismutase[J]. Pediatr Res, 2000, 47(3):395 A.
14. Gatsura SV, Zinchuk VV. Effect of enalapril maleate and losartan on the size of experimental myocardial infarction hemoglobin affinity to oxygen and various parameters of lipid peroxidation[J]. Eksp Klin Farmakol, 2004, 67(1):19-21.